Lushang Health Industry Development Co Ltd
SSE:600223
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.89
9.87
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Lushang Health Industry Development Co Ltd
Cost of Revenue
Lushang Health Industry Development Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lushang Health Industry Development Co Ltd
SSE:600223
|
Cost of Revenue
-¥2B
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
9%
|
|
|
Longfor Group Holdings Ltd
HKEX:960
|
Cost of Revenue
-¥139.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
|
China Vanke Co Ltd
SZSE:000002
|
Cost of Revenue
-¥373.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
|
Poly Developments and Holdings Group Co Ltd
SSE:600048
|
Cost of Revenue
-¥297.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
|
Y
|
Youngor Group Co Ltd
SSE:600177
|
Cost of Revenue
-¥9.4B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
|
China Merchants Shekou Industrial Zone Holdings Co Ltd
SZSE:001979
|
Cost of Revenue
-¥162.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Lushang Health Industry Development Co Ltd
Glance View
Lushang Health Industry Development Co., Ltd. engages in the real estate activities. The company is headquartered in Jinan, Shandong and currently employs 4,614 full-time employees. The company went IPO on 2000-01-13. The firm mainly develops large shopping malls, commercial pedestrian streets, residential buildings, office buildings and hotels, among others. In addition, it is engaged in the manufacture and sales of pharmaceuticals, health products, additives and cosmetics, as well as hotel business. The firm conducts its businesses primarily in Shandong, China.
See Also
What is Lushang Health Industry Development Co Ltd's Cost of Revenue?
Cost of Revenue
-2B
CNY
Based on the financial report for Sep 30, 2024, Lushang Health Industry Development Co Ltd's Cost of Revenue amounts to -2B CNY.
What is Lushang Health Industry Development Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
9%
Over the last year, the Cost of Revenue growth was 62%. The average annual Cost of Revenue growth rates for Lushang Health Industry Development Co Ltd have been 42% over the past three years , 25% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
